Breaking News

IPS Appoints Compliance Manager

By Kristin Brooks | January 31, 2014

Corbin brings 23 years of experience

Scott Corbin has been appointed regional manager of Compliance for the New England region at IPS-Integrated Project Services, Inc. Mr. Corbin has more than 23 years of experience in the biotechnology, medical device and pharma industries, including experience in regulated environments across product development and operations within medical device and biopharma research and manufacturing facilities.
 
Mr. Corbin joins the company from Luitpold Pharmaceuticals, Inc., where managed technical quality operations. Previously, he held technical leadership positions with Genzyme, Lonza Biologics, and Glaxo/Wellcome. Mr. Corbin is an accredited ASQ Quality Auditor and ISO 13485 Certified Internal Auditor.
 
“With Scott’s depth of experience, including the manufacture and validation of biologics, medical devices and pharmaceutical products, we anticipate that he will deliver tangible, long-term value for our clients,” said Dave Goswami, PE, chief executive officer and chairman, IPS. “He has demonstrated leadership in delivering innovative and cost effective solutions in validation and quality assurance along with cutting-edge manufacturing and operations expertise. With the addition of Scott, IPS is well-positioned to help achieve strategic and business goals for companies located in New England.”

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks